In the first 10 months of 2026, Ukraine reached nearly 30% vaccination coverage against human papillomavirus (HPV) among its target groups.
On World Cervical Cancer Elimination Day, WHO/Europe highlights the rollout as one example towards eliminating the disease.
Every year in Ukraine, over 3000 new cases of cervical cancer are diagnosed and up to 1100 deaths are reported. It is the fourth most common cancer among women in the country and the second most common among women aged 15–44. Around 95% of cervical cancer cases are associated with persistent HPV infection.
On 1 January 2026, Ukraine added HPV vaccination to its national immunization schedule, offering girls aged 12–13 a single dose free of charge. With less than 2 months of the year still to go, Ukraine is already close to the government’s first-year target of vaccinating 30% of eligible girls. This was also the first time in 2 decades that the schedule had been expanded to protect against an additional infection.
“Behind every one of these vaccinations is a girl who should now grow up without ever facing the threat of cervical cancer,” said Dr Silviu Domente, WHO Representative in Ukraine. “Ukraine has done this in the middle of a devastating war, and that tells you how much it matters to families here. The next step is to make sure every woman can get screened close to home and offered treatment if needed. This is a cancer we can eliminate. Ukraine is showing that it’s possible, even in the hardest of times.”
Cervical cancer is a preventable and curable disease if detected early and managed effectively. In 2022, Member States of the WHO European Region adopted the “Roadmap to accelerate the elimination of cervical cancer as a public health problem in the WHO European Region 2022–2030”.
Three years of collaboration and preparation
The HPV vaccine has been available on the private market in Ukraine since 2010. However, plans to make it available through the public system were postponed due to the burdens placed on Ukraine’s health system in the past 12 years, arising from the ongoing conflict and the COVID-19 pandemic.
Preparations for the rollout took nearly 3 years. WHO worked with the Ministry of Health, the Ukrainian Public Health Centre and other partners to develop a rollout plan, clinical guidance and recommendations for catch-up vaccination.
WHO also helped set up a multisectoral coordination mechanism and provided technical support on vaccine safety, vaccine stock management and digital reporting.
To prepare health workers, WHO assisted in the in-person training of 202 regional trainers. They went on to train 20 170 family doctors, paediatricians and nurses, about a third of Ukraine’s vaccination providers.
Support from Gavi, the Vaccine Alliance, made the rollout possible.
Closing the screening gap
According to the 2019 WHO STEPwise approach to non-communicable disease risk factor surveillance (STEPS) survey, only 53.1% of women in Ukraine had been screened for cervical cancer at least once in their lives. Yet among women whose results were positive, 91.4% received treatment.
Since 2025, cervical cancer screening has been covered by Ukraine’s Programme of Medical Guarantees, backed by a national clinical protocol released a year earlier. To put this into practice, WHO in Ukraine is supporting 2 pilot projects on screening through primary health care in Odesa, Sumy and Chernihiv regions. With support from the Government of Germany, the pilots are building clear patient pathways from screening to follow-up and referral.
Additionally, WHO supported training for 21 professionals from state laboratories on HPV testing using polymerase chain reaction (PCR). It also helped validate HPV PCR testing at the National HPV Reference Laboratory at the Chernihiv Regional Centre for Disease Control and Prevention.
Next steps towards elimination
Population displacement, health workforce shortages and reduced access to quality health services mean cervical cancer is often detected late.
WHO’s next priorities in Ukraine are to:
- support HPV PCR testing for up to 10 000 women at selected health-care facilities in targeted regions in the next months;
- train at least 135 health professionals to apply and promote national screening standards; and
- work with local health authorities and facility administrators to adopt screening algorithms and clear patient pathways.
Ukraine will need to make HPV vaccination part of routine service delivery and review coverage annually. A post-introduction evaluation will help improve delivery and inform expansion to additional age groups. Lessons from the pilots will then support the nationwide scale-up of population-based screening through primary health care.



